Pathogenesis of infections caused by SARS-CoV-2

Area of Science:

• Immunology
• Virology
• Pathology

Background:

• SARS-CoV-2 establishes mucosal infections in the respiratory and intestinal tracts.
• The virus exhibits a unique capacity to modulate host immune responses, leading to varied clinical manifestations.
• These immune modulations can mimic pyogenic bacterial infections.

Purpose of the Study:

• To elucidate the distinct mechanisms by which SARS-CoV-2 influences the immune system.
• To differentiate the clinical presentations of COVID-19, focusing on mucosal versus pneumonic forms.
• To investigate the underlying causes of extra-pulmonary organ involvement in COVID-19.

Main Methods:

• Analysis of immune response modulation by SARS-CoV-2.
• Clinical case review differentiating COVID-19 presentations.
• Pathophysiological examination of pneumonia and extra-pulmonary manifestations.

Main Results:

• SARS-CoV-2 significantly alters immune responses, complicating diagnosis.
• Natural mucosal immunity plays a critical role in limiting early viral spread.
• COVID-19 presents mainly as mucosal or pneumonic infections; pneumonia involves vascular endothelium activation and a procoagulant state.
• Viremia is not typical; extra-pulmonary effects stem from immunopathology or hormonal dysregulation.

Conclusions:

• SARS-CoV-2's immune-altering properties are central to COVID-19's diverse pathology.
• Effective mucosal immunity is key to preventing severe disease.
• Understanding these mechanisms is vital for managing COVID-19 and its long-term sequelae.